May Grydeland
Overview
Explore the profile of May Grydeland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
424
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bratteteig M, Rueegg C, Lie H, Thorsen L, Larsen E, Larsen M, et al.
J Cancer Surviv
. 2024 Sep;
PMID: 39287916
Purpose: In childhood cancer survivors (CCS), high physical activity (PA) and low sedentary time may reduce risks of late-effects. PA behaviors and screen time, and how they relate to moderate-to-vigorous...
2.
Nilsen T, Saeter M, Sarvari S, Reinertsen K, Johansen S, Edvardsen E, et al.
JMIR Res Protoc
. 2023 Nov;
12:e54462.
PMID: 37963373
[This corrects the article DOI: 10.2196/45244.].
3.
Bratteteig M, Rueegg C, Raastad T, Grydeland M, Torsvik I, Schindera C, et al.
J Adolesc Young Adult Oncol
. 2023 Sep;
13(2):338-346.
PMID: 37703544
Childhood cancer survivors have increased risk of cardiac late effects that can be potentially mitigated by physical activity and fitness. We aimed to (1) compare cardiovascular disease (CVD) risk between...
4.
Grydeland M, Bratteteig M, Rueegg C, Lie H, Thorsen L, Larsen E, et al.
Pediatrics
. 2023 Aug;
152(3).
PMID: 37646086
Objectives: Physical activity (PA) may modify risks of late effects after cancer. We aimed to examine levels of PA and sedentary time (ST) in a large, international sample of adolescent...
5.
Nilsen T, Saeter M, Sarvari S, Reinertsen K, Johansen S, Edvardsen E, et al.
JMIR Res Protoc
. 2023 Mar;
12:e45244.
PMID: 36920460
Background: Anthracycline-based chemotherapy has been mainstay of adjuvant breast cancer therapy for decades. Although effective, anthracyclines place long-term breast cancer survivors at risk of late effects, such as reduced cardiorespiratory...
6.
Matlary R, Grydeland M, Glosli H, Rueegg C, Holme P
Haemophilia
. 2023 Mar;
29(3):900-909.
PMID: 36913380
Introduction: Physical activity (PA) is influenced by numerous factors, and the literature describing why people with haemophilia (PWH) are physically active or not is inconclusive. Aims: To investigate factors associated...
7.
Matlary R, Grydeland M, Glosli H, Rueegg C, Holme P
Haemophilia
. 2023 Feb;
29(2):658-667.
PMID: 36723510
Introduction: Limited evidence exists on objectively measured habitual physical activity (PA) of young people with haemophilia (PWH). Aims: To compare different outcomes of objective PA between young PWH A and...
8.
Gotte M, Basteck S, Beller R, Gauss G, Schmidt S, Burchartz A, et al.
J Cancer Res Clin Oncol
. 2022 Oct;
149(8):4719-4729.
PMID: 36224439
Introduction: Sufficient physical activity (PA) has the potential to mitigate late effects of cancer, but objective data of PA levels in adolescents are scarce. The aim of this study was...
9.
Bratteteig M, Anderssen S, Rueegg C, Ruud E, Torsvik I, Kriemler S, et al.
Front Pediatr
. 2022 Sep;
10:977365.
PMID: 36090557
Objectives: We aimed to compare cardiovascular disease (CVD) risk factors in childhood cancer survivors (CCS) with age- and sex-stratified reference material and examine the association between physical activity (PA) intensities...
10.
Matlary R, Holme P, Glosli H, Rueegg C, Grydeland M
Haemophilia
. 2022 Jul;
28(6):e172-e180.
PMID: 35830613
Introduction: Measurement of physical activity (PA) using commercial activity trackers such as Fitbit devices has become increasingly popular, also for people with haemophilia (PWH). The accuracy of the Fitbit model...